"HR-positive, HER2-negative is the most common type of breast cancer in the United States and we frequently need to decide whether or not adjuvant chemotherapy would be beneficial, and if so ...
Neoadjuvant chemotherapy's effect on local disease management of breast cancer has a number of clinical implications, including tumor downsizing, potentially improved overall survival, and more.
The "sandwich" therapy for high risk EC appears to be tolerable and effective. Future randomized trials are necessary to compare chemo radiotherapy given in the "sandwich" fashion to other means ...